Month: October 2023

GENOMEINSIGHT_Logo

Genome Insight, Inc. Announces Groundbreaking Research Collaboration with Shriners Children’s for Patients with Adolescent Idiopathic Scoliosis

Project aims to unravel the genetic etiology of Adolescent Idiopathic Scoliosis (AIS) by leveraging Genome Insight’s whole-genome sequencing analysis and...

Pharma_Corp_Signature_Slogan_E_M_V

Meiji Seika Pharma Presents Positive Findings from Phase II Study of ME3183, Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Plaque Psoriasis at EADV Congress 2023

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Daikichiro Kobayashi) today announced that positive findings from...